Physician profile
Susan E Mackey
NPI 1457341190
$1,922.10
in general payments reported to CMS, 2019-2025
31 companies · $89.36 in 2025
The $89.36 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $193 · 2021: $197 · 2022: $539 · 2023: $426 · 2024: $311 · 2025: $89.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.67 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $359.09 | 2022-2024 | Ova1 |
| Pfizer INC. | $249.31 | 2021-2025 | |
| Abbvie INC. | $232.14 | 2019-2023 | |
| Astellas Pharma US INC | $201.88 | 2022-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $124.19 | 2020-2025 | |
| Organon LLC | $86.15 | 2021-2024 | Nexplanon |
| Avion Pharmaceuticals | $81.85 | 2019-2023 | Balcoltra |
| Merck Sharp & Dohme LLC | $69.27 | 2019-2023 | Gardasil 9 |
| Channel Medsystems, INC. | $62.40 | 2022 | |
| Coopersurgical, INC. | $50.91 | 2023-2025 | Paragard T 380a, Sos, Summit Doppler |
| Scynexis, INC. | $36.60 | 2022 | |
| Lupin INC. | $35.05 | 2020 | |
| Agile Therapeutics, INC. | $32.29 | 2021-2022 | |
| Duchesnay USA Incorporated | $28.83 | 2019 | |
| Millicent US INC | $26.70 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $21.40 | 2019 | |
| Biogen, INC. | $20.16 | 2024 | Zurzuvae |
| Pharmacosmos Therapeutics INC. | $19.66 | 2021 | |
| Hologic Sales and Service, LLC | $18.64 | 2025 | Aptima |
| Avanos Medical | $16.73 | 2019 | |
| Minerva Surgical, INC | $15.55 | 2025 | |
| Roche Diagnostics Corporation | $15.41 | 2020 | |
| Allergan, INC. | $14.49 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.34 | 2019 | |
| Mayne Pharma Commercial LLC | $13.61 | 2021 | |
| Medtronic, INC. | $13.60 | 2023 | Truclear |
| Seqirus USA INC | $13.09 | 2020 | |
| Sanofi Pasteur INC. | $12.74 | 2019 | |
| Evofem Biosciences, INC. | $12.25 | 2021 | |
| Olympus America INC. | $11.95 | 2022 | |
| Myovant Sciences INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Mackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.